Meeting
2022 ASCO Annual Meeting
Long-term outcomes of newly diagnosed CRLF2 rearranged B-cell ALL.
Authors
Jayastu Senapati
Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
Jayastu Senapati , Elias Jabbour , Nicholas James Short , Farhad Ravandi , Partow Kebriaei , Tapan M. Kadia , Gautam Borthakur , Naveen Pemmaraju , Rebecca Garris , Divyam Bansal , Sergej Konoplev , Sa A Wang , Wei Wang , Guilin Tang , Keyur P. Patel , Marina Konopleva , Nitin Jain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 7040)
DOI
10.1200/JCO.2022.40.16_suppl.7040
Abstract #
7040
Poster Bd #
271
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL).
First Author: Nicholas James Short
Poster
2017 ASCO Annual Meeting
Updated results of a phase I/II study of inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients with acute lymphoblastic leukemia.
First Author: Nicholas James Short
Poster
2023 ASCO Annual Meeting
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.
First Author: Pooja Mittal
Poster
2023 ASCO Annual Meeting
Clinical and genomic characterization of early-onset pancreatic cancer.
First Author: Florian Castet